Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/CALIFORNIA/66/395 (H2N2) Influenza Vaccine

NCT01982331 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: LAIV H2N2
OTHER: Placebo

Sponsor

PATH

Collaborators

[object Object]
[object Object]